Commentary: BMI and the need for adalimumab dose escalation in Crohn's disease – authors’ reply
E. Bultman, C. J. van der WoudeVolume:
35
Year:
2012
Language:
english
Pages:
1
DOI:
10.1111/j.1365-2036.2012.05045.x
File:
PDF, 53 KB
english, 2012